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Author Correction: Novel mutations in PIEZO1
cause an autosomal recessive generalized
lymphatic dysplasia with non-immune hydrops
fetalis
Elisavet Fotiou1,11, Silvia Martin-Almedina1,11, Michael A. Simpson2, Shin Lin3,4, Kristiana Gordon5, Glen Brice6,
Giles Atton6, Iona Jeffery7, David C. Rees8, Cyril Mignot9, Julie Vogt10, Tessa Homfray6, Michael P. Snyder4,
Stanley G. Rockson3, Steve Jeffery1, Peter S. Mortimer1, Sahar Mansour6 & Pia Ostergaard1
Correction to: Nature Communications https://doi.org/10.1038/ncomms9085, published online 03 September 2015.
This Article contains an error in the last sentence of the ‘Variant analysis suggests they are pathogenic’ section of the Results, which
incorrectly reads ‘No truncated PIEZO1 protein products were identiﬁed in western blot analysis in GLD1:II.3 and GLD2:II.2 (Fig. 2,
Supplementary Fig. 6), suggesting that the truncated protein is not stable and therefore degraded’. This should read ‘No full-size
PIEZO1 protein products were identiﬁed in western blot analysis in GLD1:II.3 and GLD2:II.2 (Fig. 2, Supplementary Fig. 6); the three
nonsense mutations are predicted to lead to premature termination of the protein, hence it is possible that those truncated proteins will
be non-functional or even unstable and degraded’. The error has not been ﬁxed in the PDF or HTML versions of the Article.
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